Suramin induces phosphorylation of the high-affinity nerve growth factor receptor in PC12 cells and dorsal root ganglion neurons

Journal of Neurochemistry

Volumn 66, Issue 3, 1996, Pages 963-972

  Gill, Jagjit S ^a   Connolly, Denise C ^b   McManus, Michael J ^a   Maihle, Nita J ^a   Windebank, Anthony J ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Chemotherapy; Nerve growth factor; Nerve growth factor receptor; Neurite outgrowth; Signal transduction; Tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PARTIAL AGONIST; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; SURAMIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPINAL GANGLION;

EID: 0030024857     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66030963.x     Document Type: Article

References (41)

1. Ahn N. G., Robbins D. J., Haycock J. W., Seger R., Cobb M. H., and Krebs E. G. (1992) Identification of an activator of the microtubule-associated protein 2 kinases ERK1 and ERK2 in PC12 cells stimulated with nerve growth factor or bradykinin. J. Neurochem. 59, 147-156.
2. Barde Y.-A. (1989) Trophic factors and neuronal survival. Neuron 2, 1525-1534.
3. Boulton T. G., Nye S. H., Robbins D. J., Ip N. Y., Radziejewska E., Morgenbesser S. D., DePinho R. A., Panayotatos N., Cobb M. H., and Yancopoulos G. D. (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65, 663-675.
4. Cardinali M., Sartor O., and Robbins K. C. (1992) Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells. J. Clin. Invest. 89, 1242-1247.
5. Chao M. V. (1992a) Neurotrophin receptors: a window into neuronal differentiation. Neuron 9, 583-593.
6. Chao M. V. (1992b) Growth factor signaling: where is the specificity? Cell 68, 995-997.
7. Coffey R. J., Leof E. B., Shipley G. D., and Moses H. L. (1987) Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J. Cell. Physiol. 132, 143-148.
8. Gill J. S. and Windebank A. J. (1995) Suramin is both a partial agonist and competitive inhibitor for the high affinity NGF receptor. (Abstr.) Ann. Neurol. 38, 308.
9. Gill J. S., Hobday K. L., and Windebank A. J. (1995) Mechanism of suramin toxicity in stable myelinating dorsal root ganglion cultures. Exp. Neurol. 133, 113-124.
10. Greene L. A. and Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424-2428.
11. Halegoua S., Armstrong R. C., and Kremer N. E. (1991) Dissecting the mode of action of a neuronal growth factor. Curr. Top. Microbiol. Immunol. 165, 119-170.
12. Hefti F., Denton T. L., Knüsel B., and Lapchak P A. (1992) Neurotrophic factors, what are they and what are they doing, in Localization and Function of Neurotrophic Factors (Cuello C., ed), pp. 25-49. Academic Press, San Diego.
13. Hosang M. (1985) Suramin binds to platelet-derived growth factor and inhibits its biological activity. J. Cell Biochem. 29, 265-273.
14. Huff K., End D., and Guroff G. (1981) Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor. J. Cell Biol. 88, 189-198.
15. Jing S., Tapley P., and Barbacid M. (1992) Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 9, 1067-1079.
16. Kaplan D. R., Hempstead B. L., Martin-Zanca D., Chao M. V., and Parada L. F. (1991a) The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252, 554-558.
17. Kaplan D. R., Martin-Zanca D., and Parada L. F. (1991b) Tyrosine phosphorylation and tyrosine kinase activity of the trk protooncogene product induced by NGF. Nature 350, 158-160.
18. Klein R., Jing S., Nanduri V., O'Rourke E., and Barbacid M (1991) The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65, 189-197.
19. La Rocca R. V., Stein C. A., Danesi R., Jamis-Dow C. A., Weiss G. H., and Myers C. E. (1990a) Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect. J. Clin. Endocrinol. Metab. 71, 497-504
20. La Rocca R. V., Stein C. A., and Myers C E. (1990b) Suramin: prototype of a new generation of antitumor compounds. Cancer Cells 2, 106-115.
21. La Rocca R. V., Danesi R., Cooper M. R., Jamis-Dow C. A., Ewing M. W., Linehan W. M., and Myers C. E. (1991a) Effect of suramin on human prostate cancer cells in vitro. J. Urol. 145, 393-398.
22. La Rocca R. V., Cooper M. R., Uhrich M., Danesi R., Walther M. M., Linehan W. M., and Myers C. E. (1991b) Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulation. Urol. Clin. North Am. 18, 123-129.
23. prototrk. Neuron 9, 1053-1065.
24. Maher P. A. (1988) Nerve growth factor induces protein-tyrosine phosphorylation. Proc. Natl. Acad Sci. USA 85, 6788-6791.
25. Olivier S., Formento P., Fischel J. L., Etienne M. C., and Milano G. (1990) Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. Eur. J. Cancer 26, 867-871.
26. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Grignani F., Pawson T., and Pelicci P. G. (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70, 93-104.
27. Pollak M. and Richard M. (1990) Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells. J. Natl. Cancer Inst. 82, 1349-1352. [Published erratum appears in J. Natl. Cancer Inst. (1990) 82, 1510.]
28. Pronk G. J., McGlade J., Pelicci G., Pawson T., and Bos J. L. (1993) Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J. Biol. Chem. 268, 5748-5753.
29. Robbins D. J. and Cobb M. H. (1992) Extracellular signal-regulated kinases 2 autophosphorylates on a subset of peptides phosphorylated in intact cells in response to insulin and nerve growth factor: analysis by peptide mapping. Mol. Biol. Cell 3, 299-308
30. Robbins D. J., Cheng M , Zhen E., Vanderbilt C. A., Feig L. A., and Cobb M. H. (1992) Evidence for a Ras-dependent extracellular signal-regulated protein kinase (ERK) cascade. Proc. Natl. Acad. Sci. USA 89, 6924-6928.
31. Rozakis-Adcock M., Fernley R., Wade J., Pawson T., and Bowtell D. (1993) The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363, 83-85.
32. Russell J. W., Windebank A. J., and Podratz J. L. (1994) Role of nerve growth factor in suramin neurotoxicity studied in vitro. Ann. Neurol. 36, 221-228.
33. Sartor O., McLellan C. A., Myers C. E., and Borner M. M. (1992) Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines. J. Clin. Invest. 90, 2166-2174.
34. Soltoff S. P., Rabin S. L., Cantley L. C., and Kaplan D. R. (1992) Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase. J. Biol. Chem. 267, 17472-17477.
35. Stephens R. M., Loeb D. M., Copeland T. D., Pawson T., Greene L. A., and Kaplan D. R. (1994) Trk receptors use redundant signal transduction pathways involving SHC and PLC-g1 to mediate NGF responses Neuron 12, 691-705.
36. Thoenen H. (1991) The changing scene of neurotrophic factors. Trends Neurosci. 14, 165-170.
37. Thomas S. M., DeMarco M., D'Arcangelo G., Halegoua S., and Brugge J. S. (1992) Ras is essential for nerve growth factor-and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 68, 1031-1040.
38. Vetter M. L., Martin-Zanca D., Parada L. F., Bishop J. M., and Kaplan D. R. (1991) Nerve growth factor rapidly stimulates tyrosine phosphorylation of phospholipase C-γ1 by a kinase activity associated with the product of the trk protooncogene. Proc. Natl. Acad. Sci. USA 88, 5650-5654.
39. Williams L. T., Tremble P. M., Lavin M. F., and Sunday M. E. (1984) Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies. J. Biol. Chem. 259, 5287-5294.
40. Windebank A. J. and Blexrud M. D. (1986) Characteristics of neurite outgrowth from rat spinal ganglia: effects of serum and segmental level. J. Neuropathol. Exp. Neurol. 45, 683-691.
41. Wood K. W., Sarnecki C., Roberts T. M., and Blenis J. (1992) ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68, 1041-1050.